{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T16:28:09Z","timestamp":1790180889886,"version":"4.1.0"},"reference-count":37,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2025,9,3]],"date-time":"2025-09-03T00:00:00Z","timestamp":1756857600000},"content-version":"vor","delay-in-days":27,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["CA282939"],"award-info":[{"award-number":["CA282939"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001927","name":"Nile Albright Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001927","id-type":"DOI","asserted-by":"publisher"}]},{"name":"The Flatley Foundation"},{"name":"The Worden Family Foundation"},{"DOI":"10.13039\/100001927","name":"Nile Albright Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001927","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Vincent Memorial Hospital Foundation"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,8,7]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Treatment of patients with platinum-resistant ovarian cancer is a major clinical challenge. We found that high expression of a meiotic protein, Synaptonemal Complex Protein 2 (SYCP2), is associated with platinum resistance and tyrosine kinase ABL1 inhibitor sensitivity in ovarian cancer. We demonstrate that tyrosine kinase ABL1 inhibitors inhibit cancer cell proliferation more efficiently in ovarian cancer cell lines with SYCP2 overexpression. Moreover, ABL1 inhibition effectively prevents tumor growth in vivo. Mechanistically, we identified a phosphorylation motif [RK]-x(2,3)-[DE]-x(2,3)-Y in SYCP2 and found that abolishing ABL1-mediated phosphorylation of SYCP2 at its tyrosine (Y) 739 within this motif renders ABL1 sensitivity of cancer cells. Importantly, ABL1 and SYCP2 colocalize at sites of R-loops after damage and promote transcription-coupled homologous recombination. Moreover, ABL1-mediated Y739 phosphorylation of SYCP2 promotes function of SYCP2 at sites of R-loops by facilitating RAD51 localization and repair, contributing to ovarian cancer cell survival. Overall, these findings highlight a novel therapeutic mechanism where ABL1 inhibitors induce cell death in platinum-resistant ovarian cancer by impairing transcription-coupled homologous recombination repair.<\/jats:p>","DOI":"10.1093\/narcan\/zcaf031","type":"journal-article","created":{"date-parts":[[2025,8,12]],"date-time":"2025-08-12T11:38:47Z","timestamp":1754998727000},"source":"Crossref","is-referenced-by-count":3,"title":["ABL1-mediated tyrosine phosphorylation of SYCP2 contributes to transcription-coupled homologous recombination and platinum resistance\u00a0in ovarian cancer"],"prefix":"10.1093","volume":"7","author":[{"given":"Boya","family":"Gao","sequence":"first","affiliation":[{"name":"Duke University School of Medicine Department of Molecular Genetics and Microbiology, , 213 Research Drive , Durham,\u00a0NC\u00a027710,","place":["United States"]},{"name":"Massachusetts General Hospital Cancer Center, Harvard Medical School , 13th Street , Charlestown , MA\u00a0 02129 ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xudong","family":"Wang","sequence":"additional","affiliation":[{"name":"Massachusetts General Hospital Cancer Center, Harvard Medical School , 13th Street , Charlestown , MA\u00a0 02129 ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa","family":"Long","sequence":"additional","affiliation":[{"name":"Duke University School of Medicine Department of Molecular Genetics and Microbiology, , 213 Research Drive , Durham,\u00a0NC\u00a027710,","place":["United States"]},{"name":"Massachusetts General Hospital Cancer Center, Harvard Medical School , 13th Street , Charlestown , MA\u00a0 02129 ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fengqi","family":"Zhang","sequence":"additional","affiliation":[{"name":"Duke University School of Medicine Department of Molecular Genetics and Microbiology, , 213 Research Drive , Durham,\u00a0NC\u00a027710,","place":["United States"]},{"name":"Massachusetts General Hospital Cancer Center, Harvard Medical School , 13th Street , Charlestown , MA\u00a0 02129 ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yumin","family":"Wang","sequence":"additional","affiliation":[{"name":"Massachusetts General Hospital Cancer Center, Harvard Medical School , 13th Street , Charlestown , MA\u00a0 02129 ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raj","family":"Kumar","sequence":"additional","affiliation":[{"name":"Division of Hematology-Oncology, Massachusetts General Hospital , 55 Fruit Street , Boston , MA\u00a0 02114 ,","place":["United States"]},{"name":"Massachusetts General Hospital Department of Medicine, , 55 Fruit Street , Boston , MA\u00a0 02114 ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irva","family":"Veillard","sequence":"additional","affiliation":[{"name":"Division of Hematology-Oncology, Massachusetts General Hospital , 55 Fruit Street , Boston , MA\u00a0 02114 ,","place":["United States"]},{"name":"Massachusetts General Hospital Department of Medicine, , 55 Fruit Street , Boston , MA\u00a0 02114 ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo\u00a0R","family":"Rueda","sequence":"additional","affiliation":[{"name":"Division of Gynecologic Oncology , Department of Obstetrics and Gynecology, Massachusetts General Hospital, 55 Fruit Street , Boston , MA\u00a0 02114 ,","place":["United States"]},{"name":"Obstetrics, Gynecology and Reproductive Biology, Harvard Medical School , 25 Shattuck Street , Boston , MA\u00a0 02115 ,","place":["United States"]},{"name":"Vincent Center for Reproductive Biology , Department of Obstetrics and Gynecology, Massachusetts General Hospital, 55 Fruit Street , Boston , MA\u00a0 02114 ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oladapo","family":"Yeku","sequence":"additional","affiliation":[{"name":"Division of Hematology-Oncology, Massachusetts General Hospital , 55 Fruit Street , Boston , MA\u00a0 02114 ,","place":["United States"]},{"name":"Massachusetts General Hospital Department of Medicine, , 55 Fruit Street , Boston , MA\u00a0 02114 ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0383-6172","authenticated-orcid":false,"given":"Li","family":"Lan","sequence":"additional","affiliation":[{"name":"Duke University School of Medicine Department of Molecular Genetics and Microbiology, , 213 Research Drive , Durham,\u00a0NC\u00a027710,","place":["United States"]},{"name":"Massachusetts General Hospital Cancer Center, Harvard Medical School , 13th Street , Charlestown , MA\u00a0 02129 ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,9,3]]},"reference":[{"key":"2025090405362490600_B1","first-page":"12","article-title":"Cancer statistics, 2024","volume":"74","author":"Siegel","year":"2024","journal-title":"CA Cancer J Clin"},{"key":"2025090405362490600_B2","doi-asserted-by":"publisher","first-page":"2182","DOI":"10.1016\/S0140-6736(21)00731-5","article-title":"Ovarian cancer population screening and mortality after long-term follow-up in the UK collaborative trial of ovarian cancer screening (UKCTOCS): a randomised controlled trial","volume":"397","author":"Menon","year":"2021","journal-title":"Lancet"},{"key":"2025090405362490600_B3","doi-asserted-by":"publisher","first-page":"896","DOI":"10.6004\/jnccn.2019.0039","article-title":"NCCN Guidelines Insights: Ovarian Cancer, Version 1.2019: Featured Updates to the NCCN Guidelines","volume":"17","author":"Armstrong","year":"2019","journal-title":"J Natl Compr Canc Netw"},{"key":"2025090405362490600_B4","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1136\/ijgc-2019-000308","article-title":"ESMO\u2013ESGO consensus conference recommendations on ovarian cancer: pathology and molecular biology, early and advanced stages, borderline tumours and recurrent disease","volume":"29","author":"Colombo","year":"2019","journal-title":"Int J Gynecol Cancer"},{"key":"2025090405362490600_B5","doi-asserted-by":"publisher","first-page":"641","DOI":"10.3390\/cancers16030641","article-title":"The poor prognosis of acquired secondary platinum resistance in ovarian cancer patients","volume":"16","author":"Elyashiv","year":"2024","journal-title":"Cancers"},{"key":"2025090405362490600_B6","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1016\/S0140-6736(18)32552-2","article-title":"Epithelial ovarian cancer","volume":"393","author":"Lheureux","year":"2019","journal-title":"Lancet"},{"key":"2025090405362490600_B7","doi-asserted-by":"publisher","first-page":"1568","DOI":"10.1038\/s41467-024-45693-2","article-title":"Meiotic protein SYCP2 confers resistance to DNA-damaging agents through R-loop-mediated DNA repair","volume":"15","author":"Wang","year":"2024","journal-title":"Nat Commun"},{"key":"2025090405362490600_B8","doi-asserted-by":"publisher","first-page":"101","DOI":"10.7150\/ijms.1.101","article-title":"Tyrosine kinase\u2014role and significance in cancer","volume":"1","author":"Paul","year":"2004","journal-title":"Int J Med Sci"},{"key":"2025090405362490600_B9","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1038\/s41467-018-02894-w","article-title":"Senataxin resolves RNA:DNA hybrids forming at DNA double-strand breaks to prevent translocations","volume":"9","author":"Cohen","year":"2018","journal-title":"Nat Commun"},{"key":"2025090405362490600_B10","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1038\/cdd.2010.132","article-title":"c-Abl tyrosine kinase in the DNA damage response: cell death and more","volume":"18","author":"Meltser","year":"2011","journal-title":"Cell Death Differ"},{"key":"2025090405362490600_B11","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1002\/cncr.11561","article-title":"Expression of c-ABL, c-KIT, and platelet-derived growth factor receptor-beta in ovarian serous carcinoma and normal ovarian surface epithelium","volume":"98","author":"Schmandt","year":"2003","journal-title":"Cancer"},{"key":"2025090405362490600_B12","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.ygyno.2013.06.031","article-title":"Overexpression of c-Abl predicts unfavorable outcome in epithelial ovarian cancer","volume":"131","author":"Zhou","year":"2013","journal-title":"Gynecol Oncol"},{"key":"2025090405362490600_B13","doi-asserted-by":"publisher","first-page":"2330","DOI":"10.1093\/nar\/gkt1233","article-title":"Novel method for site-specific induction of oxidative DNA damage reveals differences in recruitment of repair proteins to heterochromatin and euchromatin","volume":"42","author":"Lan","year":"2014","journal-title":"Nucleic Acids Res"},{"key":"2025090405362490600_B14","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1038\/s41586-021-03538-8","article-title":"RNA transcripts stimulate homologous recombination by forming DR-loops","volume":"594","author":"Ouyang","year":"2021","journal-title":"Nature"},{"key":"2025090405362490600_B15","doi-asserted-by":"publisher","first-page":"4115","DOI":"10.1038\/s41467-018-06586-3","article-title":"ROS-induced R loops trigger a transcription-coupled but BRCA1\/2-independent homologous recombination pathway through CSB","volume":"9","author":"Teng","year":"2018","journal-title":"Nat Commun"},{"key":"2025090405362490600_B16","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1007\/s00412-008-0194-0","article-title":"Protein SYCP2 provides a link between transverse filaments and lateral elements of mammalian synaptonemal complexes","volume":"118","author":"Winkel","year":"2009","journal-title":"Chromosoma"},{"key":"2025090405362490600_B17","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1083\/jcb.200603063","article-title":"Mouse SYCP2 is required for synaptonemal complex assembly and chromosomal synapsis during male meiosis","volume":"173","author":"Yang","year":"2006","journal-title":"J Cell Biol"},{"key":"2025090405362490600_B18","doi-asserted-by":"publisher","first-page":"e1008640","DOI":"10.1371\/journal.pgen.1008640","article-title":"Sycp2 is essential for synaptonemal complex assembly, early meiotic recombination and homologous pairing in zebrafish spermatocytes","volume":"16","author":"Takemoto","year":"2020","journal-title":"PLoS Genet"},{"key":"2025090405362490600_B19","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s12885-021-09138-z","article-title":"A phase IA dose-escalation study of PHI-101, a new checkpoint kinase 2 inhibitor, for platinum-resistant recurrent ovarian cancer","volume":"22","author":"Park","year":"2022","journal-title":"BMC Cancer"},{"key":"2025090405362490600_B20","doi-asserted-by":"publisher","first-page":"E3495","DOI":"10.1073\/pnas.1507105112","article-title":"DNA damage during the G0\/G1 phase triggers RNA-templated, Cockayne syndrome B-dependent homologous recombination","volume":"112","author":"Wei","year":"2015","journal-title":"Proc Natl Acad Sci USA"},{"key":"2025090405362490600_B21","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s42764-021-00045-y","article-title":"The activation mechanisms of master kinases in the DNA damage response","volume":"2","author":"Xiao","year":"2021","journal-title":"Genome Instab Dis"},{"key":"2025090405362490600_B22","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.1002\/2211-5463.13177","article-title":"c-Abl kinase regulates cell proliferation and ionizing radiation-induced G2\/M arrest via phosphorylation of FHL2","volume":"11","author":"Wang","year":"2021","journal-title":"FEBS Open Bio"},{"key":"2025090405362490600_B23","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/sj.cdd.4401336","article-title":"Requirement of caspase-mediated cleavage of c-Abl during stress-induced apoptosis","volume":"11","author":"Machuy","year":"2004","journal-title":"Cell Death Differ"},{"key":"2025090405362490600_B24","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1038\/sj.cr.7290261","article-title":"Role of c-Abl in the DNA damage stress response","volume":"15","author":"Shaul","year":"2005","journal-title":"Cell Res"},{"key":"2025090405362490600_B25","doi-asserted-by":"publisher","first-page":"612","DOI":"10.3892\/mmr.2020.11156","article-title":"c-Abl-mediated tyrosine phosphorylation of DNA damage response proteins and implications in important cellular functions (Review)","volume":"22","author":"Bohio","year":"2020","journal-title":"Mol Med Rep"},{"key":"2025090405362490600_B26","doi-asserted-by":"publisher","first-page":"5712","DOI":"10.1158\/0008-5472.CAN-17-1535","article-title":"Meiosis-like functions in oncogenesis: a new view of cancer","volume":"77","author":"McFarlane","year":"2017","journal-title":"Cancer Res"},{"key":"2025090405362490600_B27","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/1471-2407-6-6","article-title":"Upregulation of meiosis-specific genes in lymphoma cell lines following genotoxic insult and induction of mitotic catastrophe","volume":"6","author":"Kalejs","year":"2006","journal-title":"BMC Cancer"},{"key":"2025090405362490600_B28","doi-asserted-by":"publisher","first-page":"831620","DOI":"10.3389\/fgene.2022.831620","article-title":"Meiotic genes and DNA double strand break repair in cancer","volume":"13","author":"Lingg","year":"2022","journal-title":"Front Genet"},{"key":"2025090405362490600_B29","doi-asserted-by":"publisher","first-page":"e1732","DOI":"10.1038\/cddis.2015.75","article-title":"Acquisition of meiotic DNA repair regulators maintain genome stability in glioblastoma","volume":"6","author":"Rivera","year":"2015","journal-title":"Cell Death Dis"},{"key":"2025090405362490600_B30","doi-asserted-by":"publisher","first-page":"6196","DOI":"10.1158\/0008-5472.CAN-18-1377","article-title":"HORMAD1 is a negative prognostic indicator in lung adenocarcinoma and specifies resistance to oxidative and genotoxic stress","volume":"78","author":"Nichols","year":"2018","journal-title":"Cancer Res"},{"key":"2025090405362490600_B31","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1158\/2159-8290.CD-14-1092","article-title":"Genomic complexity profiling reveals that HORMAD1 overexpression contributes to homologous recombination deficiency in triple-negative breast cancers","volume":"5","author":"Watkins","year":"2015","journal-title":"Cancer Discov"},{"key":"2025090405362490600_B32","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1038\/embor.2011.221","article-title":"Synaptonemal complex protein SYCP3 impairs mitotic recombination by interfering with BRCA2","volume":"13","author":"Hosoya","year":"2011","journal-title":"EMBO Rep"},{"key":"2025090405362490600_B33","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1038\/sj.bjc.6605284","article-title":"Cell cycle genes and ovarian cancer susceptibility: a tagSNP analysis","volume":"101","author":"Cunningham","year":"2009","journal-title":"Br J Cancer"},{"key":"2025090405362490600_B34","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1038\/nrc3563","article-title":"Role of ABL family kinases in cancer: from leukaemia to solid tumours","volume":"13","author":"Greuber","year":"2013","journal-title":"Nat Rev Cancer"},{"key":"2025090405362490600_B35","doi-asserted-by":"publisher","first-page":"48944","DOI":"10.1074\/jbc.M208151200","article-title":"Regulation of ionizing radiation-induced Rad52 nuclear foci formation by c-Abl-mediated phosphorylation","volume":"277","author":"Kitao","year":"2002","journal-title":"J Biol Chem"},{"key":"2025090405362490600_B36","doi-asserted-by":"publisher","first-page":"2457","DOI":"10.21873\/anticanres.14215","article-title":"ABL1-directed inhibitors for CML: efficacy, resistance and future perspectives","volume":"40","author":"Massimino","year":"2020","journal-title":"Anticancer Res"},{"key":"2025090405362490600_B37","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1007\/s40495-018-0149-y","article-title":"Enabling tumor growth and progression: recent progress in unraveling the functions of ABL kinases in solid tumor cells","volume":"4","author":"Tripathi","year":"2018","journal-title":"Curr Pharmacol Rep"}],"container-title":["NAR Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/narcancer\/article-pdf\/7\/3\/zcaf031\/64201060\/zcaf031.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/narcancer\/article-pdf\/7\/3\/zcaf031\/64201060\/zcaf031.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,4]],"date-time":"2025-09-04T09:36:32Z","timestamp":1756978592000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/narcancer\/article\/doi\/10.1093\/narcan\/zcaf031\/8246928"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,7]]},"references-count":37,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,8,7]]}},"URL":"https:\/\/doi.org\/10.1093\/narcan\/zcaf031","relation":{},"ISSN":["2632-8674"],"issn-type":[{"value":"2632-8674","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,9]]},"published":{"date-parts":[[2025,8,7]]},"article-number":"zcaf031"}}